Follow CAP on Social Media

Listen to the CAP Podcast

China’s Decision to Join COVAX Hints at a Multilateral Approach to Its Budding Vaccine Diplomacy Agenda

Friday’s surprise announcement that China would join more than 150 other countries in the COVID-19 Vaccines Global Access Facility, or Covax, marked a sharp pivot in Beijing’s budding vaccine diplomacy strategy. Until last week, Chinese officials had resisted joining the WHO-backed vaccine alliance, hinting instead at a bilateral distribution strategy that would fulfill President Xi Jinping’s promise to make any future C19 vacinne available to Africa and other developing regions as a “global public good.”

The key question now for Africa is whether the Chinese will leverage their new relationship with Covax as a possible distribution partner for the various Chinese C19 vaccines that are now in late-stage development. Currently, four of the world’s ten vaccines in phase three clinical trials are produced by Chinese companies.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?

Independent

The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.